HomeNewsIndiaCoronavirus lockdown | PM Modi says would consider relaxations from April 20 in areas with no cases

Coronavirus lockdown | PM Modi says would consider relaxations from April 20 in areas with no cases

"We can look at some relaxations post April 20 in places where no new cases are seen - with very strict conditions," PM Modi said

April 14, 2020 / 12:33 IST
Story continues below Advertisement

Prime Minister Narendra Modi on April 14 announced an extension of the coronavirus-led lockdown until May 3 and relaxations, if any, would be considered from April 20 in areas where no new cases are seen.

"Even tougher measures to be instituted till April 20. The next one week in this fight against COVID-19 we will be more stringent in our actions. Every district, every tehsil, every city will be assessed on the preparedness and containment. We can look at some relaxations post-April 20 in places where no new cases are seen - with very strict conditions," he said.

Story continues below Advertisement

Follow our LIVE Updates on the coronavirus pandemic here

"Even if one more new case in local areas should be a cause of concern. We have to be extra vigilant with respect to current infection hotspots and the new emerging ones. We need to be even more careful in hotspots, even those areas that can convert to hotspots we will have to take strong steps to stop spread," PM Modi said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show